Armata Pharmaceuticals Inc (ARMP)
2.531
+0.03
(+1.23%)
USD |
NYAM |
Apr 25, 16:00
2.59
+0.06
(+2.34%)
Pre-Market: 20:00
Armata Pharmaceuticals Cash from Investing (TTM): -8.134M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -8.134M |
| September 30, 2023 | -5.289M |
| June 30, 2023 | -3.071M |
| March 31, 2023 | -3.985M |
| December 31, 2022 | -2.211M |
| September 30, 2022 | -2.894M |
| June 30, 2022 | -2.182M |
| March 31, 2022 | -1.242M |
| December 31, 2021 | -1.304M |
| September 30, 2021 | -1.442M |
| June 30, 2021 | -0.941M |
| March 31, 2021 | -1.018M |
| December 31, 2020 | -0.824M |
| September 30, 2020 | -0.386M |
| June 30, 2020 | -0.24M |
| March 31, 2020 | 2.915M |
| December 31, 2019 | 2.877M |
| September 30, 2019 | -6.588M |
| June 30, 2019 | 2.727M |
| March 31, 2019 | -0.186M |
| December 31, 2018 | -0.044M |
| September 30, 2018 | 9.331M |
| June 30, 2018 | -0.082M |
| March 31, 2018 | -0.053M |
| December 31, 2017 | -0.058M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.053M |
| June 30, 2017 | -0.049M |
| March 31, 2017 | -0.172M |
| December 31, 2016 | -0.279M |
| September 30, 2016 | -0.316M |
| June 30, 2016 | -0.403M |
| March 31, 2016 | -0.287M |
| December 31, 2015 | -0.21M |
| September 30, 2015 | -0.165M |
| June 30, 2015 | -0.186M |
| March 31, 2015 | -1.008M |
| December 31, 2014 | -1.202M |
| September 30, 2014 | -1.202M |
| June 30, 2014 | -1.097M |
| March 31, 2014 | -0.331M |
| December 31, 2013 | -0.102M |
| September 30, 2013 | 0.161M |
| June 30, 2013 | 0.188M |
| March 31, 2013 | 0.247M |
| September 30, 2009 | 0.148M |
| June 30, 2009 | -0.143M |
| March 31, 2009 | -0.634M |
| December 31, 2008 | -0.662M |
| September 30, 2008 | -0.782M |
| June 30, 2008 | -0.817M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-8.134M
Minimum
Dec 2023
2.915M
Maximum
Mar 2020
-1.749M
Average
-1.304M
Median
Dec 2021
Cash from Investing (TTM) Benchmarks
| AIM ImmunoTech Inc | -0.832M |
| Perspective Therapeutics Inc | 24.37M |
| Protalix BioTherapeutics Inc | -16.71M |
| Electromed Inc | -1.219M |
| Xtant Medical Holdings Inc | -24.78M |